Patent ID: 6596762
Filing Date: 2003-07-22
Classification: A61K

Abstract:
A pharmaceutical composition for treatment of a patient who has hepatic steatosis or steatohepatitis, or who has at least one symptom associated with hepatic steatosis or steatohepatitis, said composition consisting essentially of:a. soluble vitamin E in an amount of between about 10 international units per kilogram body weight of the patient per day (IU/kg/day) and about 20 IU/kg/day; b. mixed carotenoids in an amount of between about 0.1 milligram per kilogram body weight of the patient per day (mg/kg/day) and about 1 mg/kg/day; and, c. selenium in an amount of between about 0.5 microgram per kilogram body weight of the patient per day (&mgr;g/kg/day) and about 3 &mgr;g/kg/day.